Abstract
We have carried out systematic large-basis set quantum chemical computations at Møller- Plesset second-order perturbation (MP2) and couple cluster singles + doubles CCSD and CCSD(T)with triples correction levels of theories on a set of 55 halogenated carbons in the Crebelli toxicological dataset. We have computed a number of electronic properties at optimized geometries such as vertical electron affinities, HOMO-LUMO gaps, dipole moments, etc. We have provided insights into the mechanism of toxicity through electron attachment in metabolic pathways by binding to an electron donating enzyme in hepatocytes. The electron transfer from the enzyme to the halocarbon is accompanied by bond elongation resulting in autodetachment as evidenced from potential energy surfaces of the anion and neutral molecule. The autodetachment process leads to production of highly reactive free radicals, which cause tissue damage, and prolonged exposure can result in hepatocellular carcinoma depending on the hydrogen extraction propensity of the free radical and vertical electron affinity of the neutral halocarbon.
Keywords: Halocarbons toxicity, electron attachment, mechanisms of heptotoxicity, electron affinities, autodetachment.
Current Computer-Aided Drug Design
Title:Metabolic Electron Attachment as a Primary Mechanism For Toxicity Potentials of Halocarbons
Volume: 12 Issue: 1
Author(s): Krishnan Balasubramanian and Subhash C. Basak
Affiliation:
Keywords: Halocarbons toxicity, electron attachment, mechanisms of heptotoxicity, electron affinities, autodetachment.
Abstract: We have carried out systematic large-basis set quantum chemical computations at Møller- Plesset second-order perturbation (MP2) and couple cluster singles + doubles CCSD and CCSD(T)with triples correction levels of theories on a set of 55 halogenated carbons in the Crebelli toxicological dataset. We have computed a number of electronic properties at optimized geometries such as vertical electron affinities, HOMO-LUMO gaps, dipole moments, etc. We have provided insights into the mechanism of toxicity through electron attachment in metabolic pathways by binding to an electron donating enzyme in hepatocytes. The electron transfer from the enzyme to the halocarbon is accompanied by bond elongation resulting in autodetachment as evidenced from potential energy surfaces of the anion and neutral molecule. The autodetachment process leads to production of highly reactive free radicals, which cause tissue damage, and prolonged exposure can result in hepatocellular carcinoma depending on the hydrogen extraction propensity of the free radical and vertical electron affinity of the neutral halocarbon.
Export Options
About this article
Cite this article as:
Balasubramanian Krishnan and Basak C. Subhash, Metabolic Electron Attachment as a Primary Mechanism For Toxicity Potentials of Halocarbons, Current Computer-Aided Drug Design 2016; 12 (1) . https://dx.doi.org/10.2174/1573409912666160120151627
DOI https://dx.doi.org/10.2174/1573409912666160120151627 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy
Current Drug Metabolism Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Beyond Single Pathway Inhibition: MEK Inhibitors as a Platform for the Development of Pharmacological Combinations with Synergistic Anti-Leukemic Effects
Current Pharmaceutical Design Methionine-Derived Metabolites in Apoptosis: Therapeutic Opportunities for Inhibitors of their Metabolism in Chemoresistant Cancer Cells
Current Medicinal Chemistry Synthesis, Characterization and Evaluation of Cytotoxicity of New Aminophosphonic Acid Diesters in Human Leukemia Cells
Letters in Drug Design & Discovery Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
Current Medicinal Chemistry Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Current Pharmaceutical Design Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation
Current Cancer Drug Targets Synthesis and Biological Activity of Quinoxalone Derivatives as BRD4 Bromodomain Inhibitors
Letters in Drug Design & Discovery The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology A Novel Method for Screening of Anti-Cancer Drugs: Availability of Screening in Acidic Medium
Recent Patents on Biomedical Engineering (Discontinued) Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes
Current Alzheimer Research Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Current Drug Safety Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil
Anti-Cancer Agents in Medicinal Chemistry Regulatory Circuitries Coordinated by Transcription Factors and microRNAs at the Cornerstone of Hematopoietic Stem Cell Self-Renewal and Differentiation
Current Stem Cell Research & Therapy